Artax Biopharma, Inc.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
5
Active:1
Completed:4
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Phase 1
4 (100.0%)Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis
Phase 1
Active, not recruiting
- Conditions
- PsoriasisPlaque Psoriasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Artax Biopharma Inc
- Target Recruit Count
- 31
- Registration Number
- NCT05725057
- Locations
- π¬π§
Accellacare Northamptonshire, Corby, United Kingdom
π¬π§Accellacare Warwickshire, Coventry, United Kingdom
π¬π§MEU, Manchester, United Kingdom
A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Artax Biopharma Inc
- Target Recruit Count
- 64
- Registration Number
- NCT05218434
- Locations
- π¬π§
Simbec-Orion, Merthyr Tydfil, United Kingdom
Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2016-02-09
- Lead Sponsor
- Artax Biopharma Inc
- Target Recruit Count
- 32
- Registration Number
- NCT02546635
- Locations
- π¬π§
Simbec Research Ltd, Merthyr Tydfil, Cardiff Road, United Kingdom
Safety Study of Immune System Modulator for Autoimmune Diseases
- First Posted Date
- 2014-09-18
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Artax Biopharma Inc
- Target Recruit Count
- 18
- Registration Number
- NCT02243683
- Locations
- π¬π§
Simbec Research Ltd, Merthyr Tydfil, Cardiff Road, United Kingdom
News
No news found